Skip to main content

Headlines

Aprea Therapeutics' IND Application For APR-1051 Gets FDA's Nod, Shares Gain
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Phaxiam Therapeutics Says Delisting Of ADSs From Nasdaq Effective
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Is Intellia Therapeutics Stock a Buy Now?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Up 283% YTD, Is It Too Late to Buy Viking Therapeutics Stock?
posted:
by: Nasdaq NVDA Nvidia
#channels:: #All, #Business, #Technology, #NVDA, #Nasdaq, #Stocks
Apogee Therapeutics Prices Upsized Public Offering Of About 6.77 Mln Shares At $62.00/shr
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Here's Why CRISPR Therapeutics Stock Climbed 34% in February
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Akero Therapeutics Commences Public Offering Of $300 Mln Of Shares
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Nektar Therapeutics Q4 Loss decreases, but misses estimates
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy?
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
1 Wall Street Analyst Thinks Viking Therapeutics Stock Is Going to $116. Is It a Buy Around $81?
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Better Buy: Eli Lilly vs. Viking Therapeutics
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
PTC Therapeutics Breaks Above 200-Day Moving Average - Bullish for PTCT
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Celldex Therapeutics Prices Public Offering Of 8.52 Mln Shares At $47.00/shr
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets